机译:巨细胞病毒(CMV)特异性T细胞免疫重建的评估表明,基线抗病毒免疫,预防或抢先疗法而非抗胸腺细胞球蛋白治疗有助于肾脏移植受者的CMV特异性T细胞重建。
Department of Histology, Microbiology, and Medical Biotechnology, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Histology, Microbiology, and Medical Biotechnology, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Histology, Microbiology, and Medical Biotechnology, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Histology, Microbiology, and Medical Biotechnology, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Surgical and Medical Sciences-Nephrology I, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of General Surgery and Solid Organ Transplantation, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of General Surgery and Solid Organ Transplantation, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Histology, Microbiology, and Medical Biotechnology, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Histology, Microbiology, and Medical Biotechnology, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Histology, Microbiology, and Medical Biotechnology, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Surgical and Medical Sciences-Nephrology I, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Hemodialysis and Nephrology II, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of General Surgery and Solid Organ Transplantation, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Transplant Infection Diseases Unit, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
Department of Histology, Microbiology, and Medical Biotechnology, Padua General Hospital, University of Padua School of Medicine via Gabelli, Padova, Italy;
机译:对巨细胞病毒(CMV)特异性T细胞免疫重建的评估显示,基线抗病毒免疫,预防或先发制人疗法而非抗胸腺细胞球蛋白治疗对肾移植受者的CMV特异性T细胞重建有贡献。
机译:实体器官移植接受者的病毒载量,CMV特异性T细胞免疫应答和巨细胞病毒病在先发制人治疗期间发生巨细胞病毒感染的风险较高。
机译:病毒载荷,CMV特异性T细胞免疫应答和固体器官移植受体中的尖端疗法患者患者患有巨细胞病毒感染的患者的巨细胞病毒病毒。
机译:寄生干细胞移植后重建免疫系统的免疫重建与策略
机译:记忆CD8 + T细胞在持续的持续感染中仍保持功能性:对抗原特异性免疫重建和增强的影响。
机译:移植:供体CMV状态对CMV阳性移植受者中病毒感染和多功能CMV特异性T细胞重构的影响
机译:巨细胞病毒(CMV)特异性T细胞免疫重建的评估显示,基线抗病毒免疫,预防或先发制人疗法,但抗胸腺细胞球蛋白治疗无助于肾移植受者的CMV特异性T细胞重建。